DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 213 filers reported holding DEPOMED INC in Q3 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $856,000 | +1.2% | 128,313 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $846,000 | -18.1% | 128,313 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,033,000 | +39.0% | 128,313 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $743,000 | -46.1% | 128,313 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $1,378,000 | -14.4% | 128,313 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,610,000 | -35.1% | 128,313 | -6.8% | 0.00% | -33.3% |
Q4 2016 | $2,480,000 | -28.2% | 137,613 | -0.5% | 0.01% | -33.3% |
Q3 2016 | $3,456,000 | +26.5% | 138,313 | -0.6% | 0.01% | +28.6% |
Q2 2016 | $2,731,000 | +33.2% | 139,213 | -5.4% | 0.01% | +40.0% |
Q1 2016 | $2,051,000 | -23.0% | 147,213 | +0.2% | 0.01% | -28.6% |
Q4 2015 | $2,664,000 | -3.3% | 146,913 | +0.5% | 0.01% | -12.5% |
Q3 2015 | $2,754,000 | -12.1% | 146,113 | +0.1% | 0.01% | 0.0% |
Q2 2015 | $3,132,000 | +36.9% | 145,947 | +43.0% | 0.01% | +33.3% |
Q1 2015 | $2,287,000 | -14.7% | 102,050 | -38.6% | 0.01% | +100.0% |
Q4 2014 | $2,680,000 | +222.5% | 166,300 | +204.1% | 0.00% | +50.0% |
Q3 2014 | $831,000 | – | 54,679 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |